Albert David Limited (NSE:ALBERTDAVD)
India · Delayed Price · Currency is INR 815.75
+14.85 (1.85%)
Nov 11, 2026, 1:55 PM IST
Albert David Market Cap
Albert David has a market cap or net worth of 4.62 billion as of November 10, 2026. Its market cap has decreased by 4.91% in one year.
Market Cap
4.62B
Enterprise Value
2.34B
Revenue
3.64B
Global Rank
n/a
Country Rank
n/a
PE Ratio
20.63
ChartMarket Cap Chart
Since October 30, 2001, Albert David's market cap has increased from 80.47M to 4.62B, an increase of 5,638.51%. That is a compound annual growth rate of 17.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 4.62B | 9.34% |
| Dec 31, 2025 | 4.22B | -44.14% |
| Dec 31, 2024 | 7.56B | 35.71% |
| Dec 29, 2023 | 5.57B | 71.95% |
| Dec 30, 2022 | 3.24B | -6.10% |
| Dec 31, 2021 | 3.45B | 36.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anlon Healthcare | 14.31B |
| Jagsonpal Pharmaceuticals | 14.27B |
| Bafna Pharmaceuticals | 11.18B |
| Sigachi Industries | 10.39B |
| Amanta Healthcare | 7.85B |
| Valiant Laboratories | 6.06B |
| Nectar Lifesciences | 2.00B |
| Brooks Laboratories | 1.94B |